Paragraph 8 The Medicines for Human Use (Clinical Trials) Regulations 2004I1
England and Wales
The Medicines for Human Use (Clinical Trials) Regulations 2004f1 are amended as follows.
In regulation 2(1) (interpretation), in the definition of “health service body”—
in paragraph (b), after “Primary Care Trust” insert “, clinical commissioning group”; and
after paragraph (b) insert—
“(ba)the National Health Service Commissioning Board,”.
In Schedule 2 (additional provisions relating to Ethics Committees)—
in paragraph 3(5)(b)(iii), at the end of paragraph (bb) insert—
“; or
(cc)the governing body of a clinical commissioning group”; and
in paragraph 6(6)(a)(ii), after “health service body” insert “or the governing body of a clinical commissioning group”.
Annotations
Commencement
- I1
Sch. 3 para. 8 in force at 1.10.2012, see art. 1(2)(b)
Footnotes
- f1
S.I. 2004/1031. Relevant amending instruments are S.I. 2006/562, S.I. 2008/941 and S.I. 2011/2581.